Moody National Bank Trust Division’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,645
Closed -$433K 541
2023
Q3
$433K Buy
4,645
+64
+1% +$7.21K 0.03% 421
2023
Q2
$589K Hold
4,581
0.04% 334
2023
Q1
$532K Hold
4,581
0.05% 350
2022
Q4
$519K Buy
4,581
+43
+0.9% +$4.72K 0.05% 335
2022
Q3
$365K Buy
4,538
+306
+7% +$25.9K 0.04% 406
2022
Q2
$315K Buy
+4,232
New +$386K 0.03% 390

Other funds holding DXCM

Moody National Bank Trust Division's DXCM Position: Q4 2023 in Review

Moody National Bank Trust Division sold out of DexCom (DXCM) in Q4 2023, closing a stake of 4,645 shares — an estimated $433K sold.

Moody National Bank Trust Division first reported a position in DXCM in Q2 2022 and held it in 6 quarters. The position peaked at $589K in Q2 2023. 975 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • Moody National Bank Trust Division reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
  • Moody National Bank Trust Division sold 4,645 DexCom shares in Q4 2023, an estimated $433K.
  • Moody National Bank Trust Division first reported a position in DexCom in Q2 2022 and held it in 6 quarters.
  • Moody National Bank Trust Division's DexCom position peaked at $589K in Q2 2023.
  • 975 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on Moody National Bank Trust Division's 13F filing for Q4 2023, filed 11 Jan 2024.